A quite significant 33% improvement in survival was observed for mice infused with therapeutic kMSC ( Figure 3 c).
← all excerpts
Treatment with Mesenchymal Stromal Cells Overexpressing Fas-Ligand Ameliorates Acute Graft-versus-Host Disease in Mice.
1
—
—